Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Facing Potential JUUL Lawsuit Payouts and Vape Pen Recall, Manufacturer Is Now Considering Chapter 11 Bankruptcy: Reports In addition to JUUL nicotine addiction lawsuits, the company also faces a potential ban of its products from U.S. markets. October 7, 2022 Irvin Jackson Add Your Comments With thousands of JUUL nicotine addiction lawsuits moving forward in the federal court system, and U.S. regulators pushing to ban the sale of its vaping products nationwide, JUUL Labs, Inc. appears to be taking steps toward declaring Chapter 11 Bankruptcy. JUUL vape pens were introduced in 2015, with a design that appeared similar to USB drives, allowing teens to hide their vaping habit from parents and school officials. After the manufacturer aggressively marketed a variety of fruity and sweet JUUL flavors through social media influencers, the e-cigarette quickly became the most widely used among teens through the U.S. over the past decade, and fueled a vaping epidemic in the U.S., which has resulted in costs for states nationwide. As a result, the company faces the prospect of millions in JUUL lawsuit payouts being awarded, and the U.S. Food and Drug Administration (FDA) announced earlier this year that it intends to remove all JUUL products from the U.S. market, after the manufacturer failed to demonstrate that they could be marketed in a way that would avoid the risk of teens vaping. According to a report by Bloomberg News published this week, JUUL Labs has begun talking with bankruptcy lawyers regarding debtor-in-possession financing, which is a step in preparing for a bankruptcy filing. The report also indicates JUUL Labs will begin formal talks with potential lenders in the coming days. Learn More About JUUL and E-Cigarette Lawsuits Nicotine addiction and severe lung injuries from JUUL and vaping products have resulted in lawsuits against manufacturers of e-cigarettes. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About JUUL and E-Cigarette Lawsuits Nicotine addiction and severe lung injuries from JUUL and vaping products have resulted in lawsuits against manufacturers of e-cigarettes. Learn More SEE IF YOU QUALIFY FOR COMPENSATION JUUL reportedly hired bankruptcy advisors in June, after the U.S. Food and Drug Administration (FDA) decision appeared likely to result in a JUUL recall, and weeks after a federal judge cleared a JUUL vaping addiction lawsuit to go to trial. JUUL Bankruptcy Ramifications JUUL officials have cautioned that bankruptcy is just one option the company is exploring, indicating no final decision has been made. However, if the company does declare bankruptcy, it could have a significant impact on potential JUUL nicotine addiction lawsuit payouts, potentially preventing plaintiffs from being adequately compensated for their injuries. Over the past year, a number of large companies facing massive litigation have turned to Chapter 11 bankruptcy, as part of an attempt to shift liability to a subsidiary, placing a small amount of assets into that subsidiary, and declaring it to be liable for the litigation. Johnson & Johnson has been the most prominent company to engage in the scheme, which has been referred to as a “Texas Two-Step” since the reorganized company is taking advantage of Texas law to avoid paying settlements that the parent company has sufficient assets to cover. 3M Company also recently attempted the move to avoid liability in Combat Arms earplug lawsuits, by having its Aearo subsidiary. However, the Court rejected an attempt to prevent the litigation from moving forward against 3M, and the parties are currently engaged in settlement negotiations. Unlike Johnson & Johnson and 3M Company, JUUL Labs does not have as diverse a business model or revenue stream. However, the e-cigarette manufacturer is largely owned by the tobacco cigarette manufacturer Altria, which has a market cap in excess of $77 billion. October 2022 JUUL Lawsuit Update Last month, JUUL reached a $438.5 million settlement agreement with 34 states to resolve claims the company engaged in illegal marketing and sales practices, which have been blamed for causing teen nicotine addiction rates to skyrocket. However, that lawsuit payout did not resolve the thousands of individual claims filed against the company. In the federal court system, all individual JUUL addiction lawsuits filed against the company are currently consolidated before U.S. District Judge William H. Orrick III in the U.S. District Court for the Northern District of California, for coordinated discovery and pretrial proceedings. According to a pretrial schedule issued by the Court, the the first JUUL trials are expected to begin this year, to help gauge how juries are likely to respond to certain evidence and testimony that will be raised throughout the litigation over the company’s role in causing individual vaping addictions. If JUUL addiction lawsuit payouts are not reached to resolve those claims, a process may be established to start remanding hundreds of claims back to U.S. District Courts nationwide for individual trial dates in the future. Tags: Bankruptcy, Children, E-Cigarettes, Electronic Cigarettes, Juul, JUUL Recall, Nicotine, Nicotine Addiction, Vaping More JUUL E-Cigarette Vape Lawsuit Stories More Than Half of U.S. Teens Who Vape Do So To Deal With Stress, Anxiety: Study November 18, 2024 On-Line Retailers Receive FDA Warning Letter Over Illegal Sale of Disposable E-Cigarettes May 7, 2024 Vaping Causes Same DNA Damage as Smoking, Study Finds April 12, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: 2 days ago) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
On-Line Retailers Receive FDA Warning Letter Over Illegal Sale of Disposable E-Cigarettes May 7, 2024
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: 2 days ago) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)